Go Pro

GoHealth (GOCO) Competitors

GoHealth logo
$0.30 -0.01 (-2.30%)
Closing price 06/15/2026
Extended Trading
$0.30 0.00 (0.00%)
As of 06/15/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GOCO vs. CCG, FGNX, PRHI, ZBAO, and HUIZ

Should you buy GoHealth stock or one of its competitors? MarketBeat compares GoHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GoHealth include Cheche Group (CCG), FG Nexus (FGNX), Presurance (PRHI), Zhibao Technology (ZBAO), and Huize (HUIZ). These companies are all part of the "insurance" industry.

How does GoHealth compare to Cheche Group?

GoHealth (NASDAQ:GOCO) and Cheche Group (NASDAQ:CCG) are both small-cap insurance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

Cheche Group has higher revenue and earnings than GoHealth. Cheche Group is trading at a lower price-to-earnings ratio than GoHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoHealth$152.79M0.06-$257.13M-$20.29N/A
Cheche Group$430.40M0.07-$2.47M-$0.08N/A

GoHealth has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, Cheche Group has a beta of 0.17, meaning that its share price is 83% less volatile than the broader market.

GoHealth presently has a consensus target price of $5.00, suggesting a potential upside of 1,577.85%. Given GoHealth's stronger consensus rating and higher possible upside, equities analysts plainly believe GoHealth is more favorable than Cheche Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoHealth
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.20
Cheche Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Cheche Group has a net margin of 0.00% compared to GoHealth's net margin of -189.73%. Cheche Group's return on equity of 0.00% beat GoHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
GoHealth-189.73% -402.70% -7.90%
Cheche Group N/A N/A N/A

24.2% of GoHealth shares are owned by institutional investors. Comparatively, 19.8% of Cheche Group shares are owned by institutional investors. 29.1% of GoHealth shares are owned by insiders. Comparatively, 1.4% of Cheche Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Cheche Group had 1 more articles in the media than GoHealth. MarketBeat recorded 1 mentions for Cheche Group and 0 mentions for GoHealth. GoHealth's average media sentiment score of 0.00 equaled Cheche Group'saverage media sentiment score.

Company Overall Sentiment
GoHealth Neutral
Cheche Group Neutral

Summary

Cheche Group beats GoHealth on 8 of the 15 factors compared between the two stocks.

How does GoHealth compare to FG Nexus?

GoHealth (NASDAQ:GOCO) and FG Nexus (NASDAQ:FGNX) are both small-cap insurance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

FG Nexus has a net margin of 0.00% compared to GoHealth's net margin of -189.73%. FG Nexus' return on equity of -82.99% beat GoHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
GoHealth-189.73% -402.70% -7.90%
FG Nexus N/A -82.99%-62.64%

24.2% of GoHealth shares are held by institutional investors. Comparatively, 3.1% of FG Nexus shares are held by institutional investors. 29.1% of GoHealth shares are held by insiders. Comparatively, 4.1% of FG Nexus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

FG Nexus has lower revenue, but higher earnings than GoHealth. GoHealth is trading at a lower price-to-earnings ratio than FG Nexus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoHealth$152.79M0.06-$257.13M-$20.29N/A
FG Nexus$2.41M11.55-$66.74M$12.770.38

GoHealth currently has a consensus price target of $5.00, indicating a potential upside of 1,577.85%. FG Nexus has a consensus price target of $35.00, indicating a potential upside of 620.16%. Given GoHealth's higher probable upside, analysts plainly believe GoHealth is more favorable than FG Nexus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoHealth
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.20
FG Nexus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, FG Nexus had 3 more articles in the media than GoHealth. MarketBeat recorded 3 mentions for FG Nexus and 0 mentions for GoHealth. FG Nexus' average media sentiment score of 0.38 beat GoHealth's score of 0.00 indicating that FG Nexus is being referred to more favorably in the news media.

Company Overall Sentiment
GoHealth Neutral
FG Nexus Neutral

GoHealth has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, FG Nexus has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market.

Summary

FG Nexus beats GoHealth on 10 of the 17 factors compared between the two stocks.

How does GoHealth compare to Presurance?

GoHealth (NASDAQ:GOCO) and Presurance (NASDAQ:PRHI) are both small-cap insurance companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Presurance has a net margin of -41.92% compared to GoHealth's net margin of -189.73%. Presurance's return on equity of -104.13% beat GoHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
GoHealth-189.73% -402.70% -7.90%
Presurance -41.92%-104.13%-8.74%

GoHealth has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Presurance has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

24.2% of GoHealth shares are owned by institutional investors. Comparatively, 34.9% of Presurance shares are owned by institutional investors. 29.1% of GoHealth shares are owned by company insiders. Comparatively, 73.3% of Presurance shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Presurance has lower revenue, but higher earnings than GoHealth. Presurance is trading at a lower price-to-earnings ratio than GoHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoHealth$152.79M0.06-$257.13M-$20.29N/A
Presurance$43.30M0.44-$18.44M-$9.73N/A

GoHealth presently has a consensus price target of $5.00, indicating a potential upside of 1,577.85%. Presurance has a consensus price target of $7.00, indicating a potential upside of 36.72%. Given GoHealth's stronger consensus rating and higher possible upside, equities analysts plainly believe GoHealth is more favorable than Presurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoHealth
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.20
Presurance
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, GoHealth's average media sentiment score of 0.00 equaled Presurance'saverage media sentiment score.

Company Overall Sentiment
GoHealth Neutral
Presurance Neutral

Summary

GoHealth and Presurance tied by winning 7 of the 14 factors compared between the two stocks.

How does GoHealth compare to Zhibao Technology?

GoHealth (NASDAQ:GOCO) and Zhibao Technology (NASDAQ:ZBAO) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

GoHealth has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Zhibao Technology has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market.

Zhibao Technology has a net margin of 0.00% compared to GoHealth's net margin of -189.73%. Zhibao Technology's return on equity of 0.00% beat GoHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
GoHealth-189.73% -402.70% -7.90%
Zhibao Technology N/A N/A N/A

In the previous week, GoHealth's average media sentiment score of 0.00 equaled Zhibao Technology'saverage media sentiment score.

Company Overall Sentiment
GoHealth Neutral
Zhibao Technology Neutral

Zhibao Technology has lower revenue, but higher earnings than GoHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoHealth$152.79M0.06-$257.13M-$20.29N/A
Zhibao Technology$38.66M0.38-$8.66MN/AN/A

24.2% of GoHealth shares are owned by institutional investors. 29.1% of GoHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

GoHealth presently has a consensus price target of $5.00, indicating a potential upside of 1,577.85%. Given GoHealth's stronger consensus rating and higher possible upside, research analysts plainly believe GoHealth is more favorable than Zhibao Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoHealth
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.20
Zhibao Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

GoHealth and Zhibao Technology tied by winning 6 of the 12 factors compared between the two stocks.

How does GoHealth compare to Huize?

GoHealth (NASDAQ:GOCO) and Huize (NASDAQ:HUIZ) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

24.2% of GoHealth shares are owned by institutional investors. 29.1% of GoHealth shares are owned by insiders. Comparatively, 30.4% of Huize shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Huize has a net margin of 0.00% compared to GoHealth's net margin of -189.73%. Huize's return on equity of 0.00% beat GoHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
GoHealth-189.73% -402.70% -7.90%
Huize N/A N/A N/A

In the previous week, GoHealth's average media sentiment score of 0.00 equaled Huize'saverage media sentiment score.

Company Overall Sentiment
GoHealth Neutral
Huize Neutral

Huize has higher revenue and earnings than GoHealth. GoHealth is trading at a lower price-to-earnings ratio than Huize, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GoHealth$152.79M0.06-$257.13M-$20.29N/A
Huize$226.26M0.05$580K$0.0338.33

GoHealth presently has a consensus target price of $5.00, indicating a potential upside of 1,577.85%. Given GoHealth's stronger consensus rating and higher possible upside, research analysts plainly believe GoHealth is more favorable than Huize.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GoHealth
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.20
Huize
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

GoHealth has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market. Comparatively, Huize has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

Summary

Huize beats GoHealth on 8 of the 14 factors compared between the two stocks.

Get GoHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOCO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GOCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GOCO vs. The Competition

MetricGoHealthINS IndustryFinance SectorNASDAQ Exchange
Market Cap$8.60M$16.13B$14.10B$12.47B
Dividend YieldN/A3.58%5.67%6.51%
P/E Ratio-0.019.9121.3622.41
Price / Sales0.061.4343.0598.61
Price / Cash0.249.6719.4557.09
Price / Book-0.141.412.276.46
Net Income-$257.13M$1.06B$1.14B$337.01M
7 Day PerformanceN/A1.35%0.65%1.69%
1 Month Performance-59.18%4.96%2.07%0.67%
1 Year Performance-94.99%13.02%12.03%23.93%

GoHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GOCO
GoHealth
2.2742 of 5 stars
$0.30
-2.3%
$5.00
+1,577.9%
-95.0%$8.60M$152.79MN/A2,261
CCG
Cheche Group
0.3846 of 5 stars
$0.51
+14.0%
N/AN/A$34.08M$430.40MN/AN/A
FGNX
FG Nexus
2.6641 of 5 stars
$5.51
-0.3%
$35.00
+535.8%
N/A$31.60M$2.41M0.439
PRHI
Presurance
3.5365 of 5 stars
$4.99
-5.9%
$7.00
+40.4%
N/A$19.11M$32.52MN/A150
ZBAO
Zhibao Technology
N/A$0.45
-4.2%
N/A-55.5%$14.65M$38.66MN/A148

Related Companies and Tools


This page (NASDAQ:GOCO) was last updated on 7/4/2026 by MarketBeat.com Staff.
From Our Partners